Indivior Pharmaceuticals Inc. Common Stock vs Park Hotels & Resorts Inc. Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while Park Hotels & Resorts Inc. Common Stock trades at $15.12 (market cap $3.14B). The key difference: Indivior Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Park Hotels & Resorts Inc. Common Stock pays a 6.41% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Park Hotels & Resorts Inc. Common Stock for 0 Days on average.
| INDV | PK | |
|---|---|---|
Market Cap | $4.18B | $3.14B |
Volume | 1,819,746 | 3,553,985 |
Sector | Health | Real Estate |
52-Week High | $41.83 | $16.17 |
52-Week Low | $24.09 | $9.84 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.47B | $6.98B |
Dividend Yield | — | 6.41% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →Park Hotels & Resorts Inc. is a US lodging REIT, spun off from Hilton Worldwide in 2017, that owns a portfolio of premium-branded hotels and resorts in major urban, resort, and convention markets.
Read more on PK →